| scholarly article | Q13442814 |
| P2093 | author name string | T E Hugli | |
| M S Kawahara | |||
| P H Pfeifer | |||
| P433 | issue | 8 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1190-1199 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Possible mechanism for in vitro complement activation in blood and plasma samples: futhan/EDTA controls in vitro complement activation | |
| P478 | volume | 45 |
| Q60922350 | A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity |
| Q36636420 | Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma |
| Q37191878 | Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. |
| Q79635737 | Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein |
| Q35763276 | Complement Activation in Patients with Focal Segmental Glomerulosclerosis |
| Q35862436 | Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease |
| Q42912187 | Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover |
| Q51217342 | Complement activation is involved in biological responses to leukocyte adsorptive apheresis. |
| Q36302426 | Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity |
| Q36464489 | In vitro and in vivo gene delivery by recombinant baculoviruses. |
| Q35579838 | Modern complement analysis |
| Q35882064 | New advances in measurement of complement activation: lessons of systemic lupus erythematosus |
| Q38645385 | Potential Roles for C1 Inhibitor in Transplantation |
| Q37312374 | Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus |
| Q55147541 | The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus. |
| Q33710235 | The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart |
Search more.